International Journal of Stem Cells · 2016 · 10 citations · 18 references
Life SciencesImmunologyCell TherapyRegenerative MedicineStem Cell BiologyAutologous Stem Cell TransplantationMesenchymal Stem Cell TherapyMultiple SclerosisAutologous Stem Cell InfusionAutologous Stem Cell TherapyBone Marrow Stem Cell InfusionDisability Status AnalysisDisability Status DeterminationMultiple Sclerosis TherapyRandomized ExperimentsStem Cell-based Therapy
Stem cell therapy, an evolving, progressive field of therapeutics has shown several successes in areas where classic treatments failed to prevent or stop disability. Starting in 2009, twenty two sequential patients with progressive Multiple Sclerosis (MS) courses were treated with Autologous Bone Marrow Mononuclear stem cells (BM-MNSCs). The cells were given both intravenously and intrathecally. Using the Expanded Disability Status Scale (EDSS) score for evaluation, our data indicates that the majority of the patients benefited on the average one point on the scale. This paper adds to the body of evidence suggesting the safety and efficacy of autologous BM-MNSCs in the treatment of MS and awaits validation through larger, randomized studies.
18
Alastair Compston, Alasdair Coles · The Lancet · 2008 · 4.3K citations
New Multiple Sclerosis Phenotypic Classification
Fred Lublin · European Neurology · 2014 · 4.3K citations
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations
Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell
Diane S. Krause, Neil D. Theise, Michael I. Collector et al. · Cell · 2001 · 2.7K citations · Full text